AltheaDx, a pharmacogenomics company, about to receive approval from MolDx on reimbursement for it’s latest offering, needed a validated business model that balanced a vertical focus with the ability to serve many markets over time.
With an initial need to secure the next round of funding, we framed the strategic positioning and messaging for their investment efforts, but more importantly validated a formal platform approach to deliver for several prioritized verticals over time. Included were the actionable business strategy, marketing, product experience, commercial and more.